Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates, Chartered Accountants, as its statutory auditors for a five-year term. The appointment follows the expiry of the previous auditor's tenure at the conclusion of the company's 34th Annual General Meeting (AGM).

The new firm will hold office from the conclusion of the 34th AGM, held on September 23, 2026, until the conclusion of the 39th AGM scheduled for 2031. This change was approved by shareholders during the annual meeting, in compliance with the Companies Act, 2013, which restricts the reappointment of auditors beyond a specified period.

Auditor Transition Details

The outgoing auditors, M/s Shah & Savla LLP, Chartered Accountants (Firm Registration No. 109364W / W100143), retired upon completing their ten-year term. The company stated that the change is solely due to the expiry of the existing tenure and that the outgoing auditors have not raised any concerns or issues regarding their departure.

M/s Divyesh J Shah & Associates (Firm Registration No. 118227W) is a professionally managed firm established in 1998. The firm offers chartered audit, management consultancy, tax consultancy, accounting services, manpower management, and secretarial services. It consists of distinguished chartered accountants, corporate financial advisors, and tax consultants.

Compliance and Disclosure

The intimation was filed with BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD1/114/2019 dated October 18, 2019. The disclosure includes details required under Schedule III of the Listing Regulations.

Nishant Kankaria, Company Secretary and Compliance Officer, signed the filing on September 24, 2026, confirming the details provided in the annexures attached to the regulatory submission.

Samrat Pharmachem Limited reported an increase in topline revenue for FY26, though profitability metrics deteriorated significantly compared to the previous year. The pharmaceutical chemicals manufacturer recorded revenue of ₹289.72 crore, up from ₹285.86 crore in FY25. Despite the marginal top-line growth, EBITDA swung to a loss of ₹3.94 crore against a profit of ₹11.87 crore in the prior fiscal year.

The company disclosed these figures during its 34th Annual General Meeting held on September 23, 2026, via video conferencing. The meeting was chaired by Rajesh Mehta, Executive Director, who highlighted that the company incurred capital expenditure of approximately ₹6.29 crore during the financial year. Management stated that this investment is intended to boost production and sales capacity, aiming to cater to local manufacturers and meet export demands.

Financial Performance Overview

The shift in profitability amidst flat-to-slightly-up revenue growth suggests margin pressure or increased operational costs during FY26. The company did not disclose specific reasons for the EBITDA decline in the AGM summary, but noted plans to add new products to its existing range to drive future growth.

What the Numbers Show

A divergence is visible between the modest revenue expansion of roughly 1.4% and the sharp contraction in operating profitability. While revenue grew by ₹3.86 crore, EBITDA declined by ₹15.81 crore year-on-year. This indicates that costs rose disproportionately faster than sales, or that the new product additions and capex investments are currently weighing on margins before contributing to revenue conversion.

AGM Proceedings and Resolutions

The meeting was attended by 39 members through video conferencing. Key resolutions passed included:

• Adoption of audited standalone financial statements for FY26.
• Re-appointment of Megh Mehta as Executive Director.
• Appointment of statutory auditor and ratification of cost auditor remuneration.

The Statutory Auditor’s report for FY26 was unqualified. However, the Secretarial Auditor’s report was qualified, with observations read out by Practising Company Secretary Aqueel Mulla during the meeting. One shareholder raised questions regarding future prospects, which were addressed by the Chairman.

Voting Results and Scrutiny

On September 24, 2026, the company submitted the Consolidated Scrutinizer's Report for the remote e-voting and e-voting conducted at the AGM. All four ordinary resolutions were duly approved by shareholders with the requisite majority.

The scrutiny was conducted by Aqueel A Mulla, Proprietor of A.A. Mulla & Associates. The voting process utilized the electronic voting system provided by MUFG Intime India Private Limited (MUFGIPL). The cut-off date for determining eligible shareholders was September 16, 2026.

Resolution Outcomes

All resolutions passed by simple majority. The detailed voting summary is as follows:

Promoter and promoter group members voted exclusively in favor of all resolutions, casting 1,397,467 votes. Among public non-institutional shareholders, a small dissent was recorded, with 35,000 votes cast against each resolution via remote e-voting.